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Abstract
Purpose: Physiologic monitors are plagued with alarms that create a cacophony of sounds and visual alerts causing ‘‘alarm
fatigue’’ which creates an unsafe patient environment because a life-threatening event may be missed in this milieu of
sensory overload. Using a state-of-the-art technology acquisition infrastructure, all monitor data including 7 ECG leads, all
pressure, SpO2, and respiration waveforms as well as user settings and alarms were stored on 461 adults treated in intensive
care units. Using a well-defined alarm annotation protocol, nurse scientists with 95% inter-rater reliability annotated 12,671
arrhythmia alarms.
Results: A total of 2,558,760 unique alarms occurred in the 31-day study period: arrhythmia, 1,154,201; parameter, 612,927;
technical, 791,632. There were 381,560 audible alarms for an audible alarm burden of 187/bed/day. 88.8% of the 12,671
annotated arrhythmia alarms were false positives. Conditions causing excessive alarms included inappropriate alarm
settings, persistent atrial fibrillation, and non-actionable events such as PVC’s and brief spikes in ST segments. Low
amplitude QRS complexes in some, but not all available ECG leads caused undercounting and false arrhythmia alarms. Wide
QRS complexes due to bundle branch block or ventricular pacemaker rhythm caused false alarms. 93% of the 168 true
ventricular tachycardia alarms were not sustained long enough to warrant treatment.
Discussion: The excessive number of physiologic monitor alarms is a complex interplay of inappropriate user settings,
patient conditions, and algorithm deficiencies. Device solutions should focus on use of all available ECG leads to identify
non-artifact leads and leads with adequate QRS amplitude. Devices should provide prompts to aide in more appropriate
tailoring of alarm settings to individual patients. Atrial fibrillation alarms should be limited to new onset and termination of
the arrhythmia and delays for ST-segment and other parameter alarms should be configurable. Because computer devices
are more reliable than humans, an opportunity exists to improve physiologic monitoring and reduce alarm fatigue.
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Introduction
Critical care clinicians rely heavily upon information provided
by physiologic monitor devices for minute-to-minute clinical
decision-making in hospital intensive care units (ICUs) (Figure 1).
Waveforms routinely displayed at the bedside and central stations
include electrocardiograms (ECGs), respiration, invasive pressures
(arterial, pulmonary artery, central venous, intra-cranial), and
peripheral oxygen saturation (SpO2). The monitor device’s
computer also makes frequent measurements of a myriad of vital
sign parameters such as heart rate, respiratory rate, SpO2, systolic,
diastolic, and mean values for all available pressures, just to name
a few. When any of these individual parameters fall outside the
‘‘too low’’ or ‘‘too high’’ alarm thresholds for a few seconds, an
alarm is triggered which may sound an audible tone or visual text
message.
In addition to the plethora of parameter alarms, physiologic
monitor devices also contain arrhythmia computer algorithms that
PLOS ONE | www.plosone.org 1 October 2014 | Volume 9 | Issue 10 | e110274
trigger an alarm when a change in cardiac rhythm is detected.
Critical arrhythmia alarms such as asystole or ventricular
fibrillation are configured as ‘‘latching’’ alarms that produce
incessant sounds that do not cease until a clinician silences the
alarm. All too often, these incessant alarms are triggered by
something as benign as motion artifact from activities such as
brushing one’s teeth. The end result is that clinicians are exposed
to a high number of physiologic monitor alarms over the span of
their 8–12 hour shift causing excessive alarm burden.
In 2010, excessive alarm burden was exposed by the press as a
patient safety concern by the highly-publicized death of a patient
who was being monitored at a prestigious medical center. Despite
multiple low heart rate alarms that occurred prior to the patient’s
cardiac arrest, no-one working on the unit that day recalled
hearing the alarms. In the investigation that ensued, the Centers
for Medicare and Medicaid Services reported: ‘‘Nurses not
recalling hearing low heart rate alarms were indicative of alarm
fatigue which contributed to the patient’s death’’ [1].
Alarm fatigue occurs when clinicians are desensitized by
numerous alarms, many of which are false or clinically irrelevant.
As a result, the cacophony of alarm sounds becomes ‘‘background
noise’’ that is perceived as the normal working environment in the
ICU. Importantly, alarms may be silenced at the central station
without checking the patient or permanently disabled by clinicians
who find the constant audible or textual messages bothersome.
The Association for the Advancement of Medical Instrumentation
and the U.S. Food & Drug Administration have warned of deaths
due to alarm silencing on patient monitor devices [2]. Likewise, a
number of other federal agencies and national organizations have
issued alerts about alarm fatigue being a major patient safety
concern. For example, the Emergency Care Research Institute, a
leading nonprofit organization, lists alarm fatigue as the number
one health technology hazard for 2014 [3]. In addition, the Joint
Commission that approves hospitals for accreditation issued an
alarm safety alert in 2013; in 2014, they established alarm safety as
a National Patient Safety Goal, and further regulations will be
compulsory in 2016 [4].
To date, there has not been a comprehensive investigation of
the frequency, types, and accuracy of physiologic monitor alarms
collected in a ‘‘real-world’’ ICU setting. For this reason, nurse and
engineer scientists in the ECG Monitoring Research Laboratory at
the University of California, San Francisco (UCSF) designed a
Figure 1. Physiologic monitor device in Intensive Care Unit. Bedside patient monitor (GE Healthcare, Milwaukee, WI) displays multiple
physiologic waveforms and vital sign measurements. The nurse pictured here gave written informed consent to publish this photograph supplied by
the San Francisco Chronicle newspaper (with permission) for their story on alarm fatigue at: http://www.sfgate.com/health/article/Hospitals-look-to-
reduce-danger-of-alarm-fatigue-4918018.php.
doi:10.1371/journal.pone.0110274.g001
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study to provide complete data on monitor alarms. In addition to
alarm frequency and accuracy, further questions the investigators
explored were: 1) Are false arrhythmia alarms due to poor ECG
signal quality that might be resolved by a better skin prep/
electrode regimen? 2) How important is it to analyze all available
ECG leads for arrhythmia diagnosis? 3) How often are non-ECG
waveforms (e.g., pressures, SpO2) needed for arrhythmia diagno-
sis? 4) How often are ventricular arrhythmia alarms clinically
relevant in terms of meeting published practice guideline criteria
for treatment in hospital settings?
The purpose of this paper is to report results of an initial analysis
of data collected during the 31 days of March, 2013. We have
included ECG figures of alarm conditions that illustrate all the key
findings. Also discussed are insights that shed light on the problem
of excessive alarm burden with recommendations to provide
guidance for developing solutions to address the problem of
clinical alarm fatigue.
Methods
Research Design and Setting
The UCSF Alarm Study used a prospective data collection
design with a state-of-the-art technology infrastructure to collect all
available physiologic waveforms, computer vital sign measure-
ments, clinician alarm settings, and alarms that occurred in the
medical center’s five adult ICUs. The patient populations treated
in these five units span the breadth of clinical disorders (medical,
surgical, cardiac, and neurologic) treated in a large tertiary-
quaternary medical center as summarized in Table 1. The UCSF
Committee on Human Research approved the study with waiver
of patient consent because all ICU patients have physiologic
monitoring as part of their routine care and acquisition and
storage of this data did not influence their clinical care. A major
advantage of the waiver of patient consent is that all consecutive
patients treated in these ICUs were included in the study; no
patients were excluded from the analysis. The nurse pictured in
Figure 1 has provided consent for publication.
Collection of Waveform and Alarm Data
Figure 2 illustrates the hospital infrastructure that was installed
to automatically store the physiologic monitor data for the UCSF
Alarm Study. Each of the 77 ICU beds is equipped with a Solar
8000i bedside monitor (version 5.4 software, GE Healthcare,
Milwaukee, WI) that acquires, processes, and stores data. A closed
network connects all bedside monitors and central monitoring
stations. The CARESCAPE Gateway system (GE Healthcare,
Milwaukee, WI) enables study data to securely pass out of the
network to an external server to be analyzed retrospectively.
A special research version of CARESCAPE Gateway was built
to collect comprehensive alarm data such as nurse-determined
individual patient alarm settings and all unique alarms including
message (inaudible) and technical alarms. In prior research,
investigators have reported only on audible alarms because they
are thought to contribute more to alarm fatigue than inaudible
alarms. Our rationale for collecting inaudible as well as audible
alarms is that nurses (and sometimes patients) notice text message
alarms displayed on the bedside monitor. Thus, they do raise
concern about whether something is wrong and require thought
about whether a response is necessary. Inaudible technical alarms
may signal a problem that, if uncorrected, will lead to complete
suspension of arrhythmia detection. Moreover, these technical
alarms may provide a sensitive marker to determine the efficacy of
interventions such as optimal electrode regimens. For example, a
technical message on the monitor that says ‘‘Artifact’’ indicates a
noisy ECG signal but it does not sound an audible alarm nor does
it suspend arrhythmia detection. However, if the artifact
continues, it will trigger an ‘‘Arrhythmia Suspend’’ alarm that
completely suspends all (including lethal) arrhythmia detection,
putting the patient in a unsafe environment.
BedMasterEx software (Excel Medical Electronics, Inc, Jupiter,
FL) was installed to store physiologic waveforms, vital signs
(device-measured parameters), alarm settings, and monitor alarms
in a relational database (SQL ServerTM). The waveform data were
saved in flat files following a proprietary format. The vendor of
BedMasterEx software provided a command-line software utility
to extract waveform data into Extensible Markup Langue (XML)
files. The investigators further developed an application to parse
these XML files, detect gaps in the data streams, alternations of
signal channel configurations, and then assemble the waveform
data into multiple binary files following the publicly available
format from AD Instrument (Dunedin, New Zealand). These
binary files can be reviewed using a free software application
LabChart Reader from AD Instrument. In addition, these files can
be readily loaded into analytics programs including Matlab for
further analysis.
All waveform signals were acquired including ECG (240 Hz),
invasive pressures (120 Hz), and SpO2 (60 Hz). Each waveform
sample was represented with 12 bits. In addition, the scale factors
of each channel as specified by BedMasterEx were stored in the
corresponding fields in binary file header to enable the
reconstruction of samples in the original physical units.
In the pilot phase of the study, the investigators realized they
could not depend on the accuracy of the medical record numbers
Table 1. UCSF Alarm Study Units.
Hospital Unit # Beds Patient Population
2 Intensive Care Units 32 Critically-ill adults with complex medical disorders and post-operative general surgery, solid organ transplant, acute
kidney injury, acute and end-stage liver failure, sepsis, multiple organ dysfunction syndrome, and liver, pancreas or
small bowel transplantation. Patients commonly on mechanical ventilation.
Cardiac Critical Care 16 Critically-ill adults with cardiac disorders, including cardiac medicine, cardiothoracic surgery, transplant (heart, lung,
heart & lung), thoracic or vascular surgery. Patients with left ventricular assist devices, pacemakers, & implantable
cardioverter devices.
2 Neuroscience Care Units 29 Critically-ill adults with neurological impairment (subarachnoid hemorrhage, stroke, brain tumors, traumatic brain
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as inputted in the patient monitors to find monitor data for a given
patient because of human errors at the bedside. To solve this
problem, patient bed transfer histories were extracted from the
hospital electronic medical record system. This established a
correct association between medical record number and waveform
data by determining the location of a given patient first and then
retrieving the corresponding database records in the relational
database based on the patient location and time information.
Patient Monitoring ECG Lead Configuration and Alarm
Default Settings
A five-electrode ECG lead configuration was used for all
patients (Figure 3) resulting in seven available leads (I, II, III, aVR,
aVL, aVF, and V). Although only two ECG leads were displayed
on the bedside monitor, all seven leads were stored and available
to the investigators for arrhythmia alarm annotation.
Table 2 shows the alarm default settings recommended by the
manufacturer (factory defaults) and the UCSF default settings used
during the 31-day study period. Some non-lethal alarms can be
configured by the nurse to change an audible alarm to an
inaudible message. However, all technical alarms are not
configurable so the factory default settings are permanent.
Annotation of Arrhythmia Alarms
Six arrhythmia alarms that were considered clinically important
enough to be set as audible alarms were determined to be true or
false by clinical experts using a standardized protocol developed
for the study. The alarm annotation protocol is shown in Table 3
with alarm definitions and the criteria used for judging whether
the six alarms were true or false positives. The annotators were
four nurse scientists (co-authors PH, JZH, TM, DS), all of whom
had PhD training and clinical experience with physiologic
monitoring devices in hospital settings. All annotators completed
a formal 10-week course in clinical electrocardiography that has
been taught by the Principal Investigator (PI, BJD) at UCSF for
the past 33 years. In addition, they underwent a 3-hour alarm
annotation certification course taught by the PI that was video-
taped for review as needed. The PI and four annotators met in-
person weekly and were in almost daily email communication
during the alarm annotation period to review cases and reach
consensus about an accurate and consistent method of arrhythmia
alarm interpretation.
The BedMasterEx vendor provided two pages of waveforms for
each alarm that were used by the annotators in their analysis. The
first page displayed a 10-second rhythm strip of the seven available
ECG leads at the time the alarm was triggered. The second page
displayed the same alarm event with fewer ECG leads and all
available non-ECG waveforms. When more than a 10-second
rhythm strip was necessary for alarm annotation, the annotator
pulled up the alarm on the BedMaster Client viewer and scrolled
backward and forward as needed. An example of the first and
second page of a true positive ventricular tachycardia alarm is
shown in Figures 4 and 5. Figures 6 and 7 illustrate an example of
a false positive ventricular tachycardia alarm.
Inter-rater reliability of alarm annotation was tested by
randomly selecting 300 alarms that were rated twice by pairs of
the annotators. A Cohen’s Kappa was run to compare ‘‘Rater 10
to ‘‘Rater 2.’’ There was 95% agreement as to whether the alarm
was a true or false positive (Cohen’s Kappa score of 0.86). The
disagreements were settled by the PI and the database was
corrected accordingly.
Analysis of Alarm Frequency and Type
All unique alarms for the 31-day period were grouped into three
main categories: arrhythmia, parameter, and technical alarms. For
analysis and reporting purposes, individual alarms of similar type
were grouped into 17 categories as shown in Table 4.
Analysis of ECG Signal Quality
Each annotated arrhythmia alarm was rated by the investigators
as having good, fair, or poor signal quality. Good signal quality
was defined as a clearly visible P-QRS-T waveform across all
Figure 2. Hospital infrastructure to automatically store all physiologic monitor waveform and alarm data.
doi:10.1371/journal.pone.0110274.g002
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available leads with little to no noise, baseline wander, or leads off.
Fair signal quality was defined as moderate noise or baseline
wander but having identifiable QRS complexes for basic rhythm/
rate detection. Poor signal quality was defined as being unanalyz-
able because of excessive noise, baseline wander or leads off.
Patient Data
Data were collected on patient demographics (age, race,
ethnicity, gender), final diagnosis, and patient outcome variables
of interest including cardiac or respiratory arrest (‘‘Code Blue’’)
and in-hospital death.
Electrocardiographic conditions hypothesized to trigger false
ventricular arrhythmia alarms were collected from hospital-
acquired standard ‘‘diagnostic’’ 12-lead ECGs including the
presence of a widened QRS complex due to right or left bundle
branch block or ventricular pacemaker rhythms. In annotating
alarms for patients with pacemakers, data were collected on
whether or not nurses had activated the PaceMode feature on the
monitor device that provides a separate algorithm with higher
sampling rate to detect pacemaker stimuli.
Patient factors hypothesized to cause alarms by affecting signal
quality or QRS amplitude were also collected including body mass
index, current smoker status that is likely to cause agitation with
nicotine withdrawal, confused mental status, tremor, seizures, and
use of devices known to cause electrical interference such as
hypothermia or ventricular assist devices.
Statistical Analyses
Descriptive statistics (frequencies, proportions, means and
standard deviations) were used to depict the total number of
unique alarms and alarms by category. Audible alarm burden was
calculated as the number of audible alarms per bed per day.
Hourly alarm rates for each patient were determined by first
calculating each patient’s total monitoring time. A computer
algorithm developed by one of the investigators (YB) eliminated
periods when the patient was detached from the ICU monitor
device (e.g., for surgery, cardiac catheterization, or other off-unit
diagnostic procedure), as evidenced by flat lines on the seven ECG
leads. Hourly rates for any alarm could then be calculated by
dividing the number of alarms by the patient’s total monitoring
time. By normalizing the alarms in this way, patients with different
ICU lengths of stay could be compared and an analysis could be




A total of 461 patients were treated in the five ICUs during the
31-day period of March, 2013 and all were included in the
analysis. The average daily census during this month for the 77
ICU beds was 65.9 patients. Patients’ average monitoring time was
104.5 hours; median, 52.9 hours; minimum to maximum range,
5.3–744.0 hours. Of the total of 461 subjects, 17 (3.7%)
experienced a cardiac or respiratory arrest during the 31-day
period of the study. Overall in-hospital mortality for the cohort of
461 subjects was 35 (7.6%).
The sample had a mean age of 60617 years and 250 (54%)
were male. Race/ethnicity reflected the diversity of the San
Francisco Bay area with 180 (39%) from non-white minorities. Of
the total 461 patients, 83 (18%) were treated for a cardiac medical
or surgical diagnosis, 197 (43%) were treated for a neurologic or
neurosurgical diagnosis, and 181 (39%) were treated for another
medical-surgical (pulmonary, sepsis, multi-system organ failure,
etc) diagnosis. One hundred sixty-five patients (35.8%) were on
mechanical ventilation. Patients who had a baseline cardiac
rhythm with a wide QRS complex were as follows: right or left
bundle branch block, 41 (8.9%); temporary or permanent
ventricular pacemaker rhythm, 48 (10.4%).
Overall Alarm Frequency and Type
Over the total monitoring time of 48,173 hours, there were a
total of 2,558,760 unique audible and inaudible (visual text
message) alarms in the five ICUs during the 31-day period. Of this
total, 1,154,201 were arrhythmia alarms, 612,927 were vital sign
parameter (‘‘too low - too high’’) alarms, and 791,632 were
Figure 3. Patient monitoring ECG lead configuration. A 5-electrode lead configuration was used in all study ICUs with Mason-Likar electrode
placement of the limb leads on the torso and one chest electrode that is routinely placed in the V1 location.
doi:10.1371/journal.pone.0110274.g003
Alarm Fatigue with Patient Monitoring
PLOS ONE | www.plosone.org 5 October 2014 | Volume 9 | Issue 10 | e110274
Table 2. Alarm Default Settings for Adult ICUs during the Study Period.
Patient Status Arrhythmia Alarms
Alarm Sounds: Crisis, 3 beeps continually; Warning, 2 beeps; Advisory, 1 beep; Message, inaudible text
Alarm Factory Default UCSF Default
Asystole Crisis Crisis
Ventricular Fibrillation/Ventricular Tachycardia Crisis Crisis
Ventricular Tachycardia Crisis Crisis
Ventricular Tachycardia .2 Crisis Advisory
Ventricular Bradycardia Crisis Warning








Premature ventricular contraction (PVC) Message Message
Irregular Message Message
Atrial Fibrillation Message Advisory
Patient Status Parameter Limit Violation Alarms (selected)
Alarm Sounds: Warning, 2 beeps; Advisory, 1 beep; Message, inaudible text
Alarm Factory Default UCSF Default
Heart Rate 50/150 Warning 50/130 Warning
PVC/minute 6 Message 10 Message
Invasive arterial pressure Advisory 90/160 Warning
Noninvasive blood pressure Advisory 90/160 Advisory
ST segment Advisory Advisory
Respiratory Rate Message Warning
No Breath/Apnea Warning Warning
Peripheral oxygen saturation (SpO2) Advisory 90% Advisory
System Status Technical Alarms (selected)
Alarm Sounds: Warning, continuous foghorn tone; Message, inaudible text
Alarm Factory Default UCSF Default
Artifact Message Message
Lead Fail (single lead I or II or III or RL or V) Message Message
ECG Leads Fail Warning Warning
Respiratory Leads Fail Warning Warning
Arrhythmia Suspend Warning Warning
Invasive Pressure Sensor Fail Warning Warning
Noninvasive Blood Pressure Deflation Failure Warning Warning
Noninvasive Blood Pressure Exceed 3 Minutes Warning Warning
Noninvasive Blood Pressure Excessive Pressure 200 Warning Warning
Noninvasive Blood Pressure Invalid Command Warning Warning
doi:10.1371/journal.pone.0110274.t002
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Table 3. Alarm Annotation Protocol.
Alarm Label & Algorithm Definition Proof of True versus False Alarm by Investigator
1. ASYSTOLE Displayed heart rate
drops to zero. No QRS detected for
,5–6 seconds
Proof of True Positive: (either #1 or #2 confirms true alarm)
1. Simultaneous drop in invasive arterial or pulmonary artery (PA) pressure to near zero
2. Documentation from electronic medical record (EMR) of asystolic cardiac arrest at same time
Proof of False Positive: (any of the following confirms false positive alarm)
1. No simultaneous decrease in invasive arterial or PA pressure
2. A visible QRS is evident in at least one ECG lead (examine all 7 available leads)
3. Good quality SpO2 signal has pulsatile waveform that matches rate of underlying baseline rhythm
4. ASYSTOLE alarm duration is .60 seconds but there is no EMR documentation that it was recognized clinically
(syncope, seizure, loss of consciousness, cardiac arrest)
2. VFIB/VTAC Coarse flutter waves
without QRS complexes
Proof of True Positive: (either #1 or #2 confirms true alarm)
1. Simultaneous drop in invasive arterial or PA pressure to near zero
2. Documentation from EMR of ventricular tachycardia or fibrillation cardiac arrest at same time
Proof of False Positive: (any of the following confirms false positive alarm)
1. No simultaneous decrease in invasive arterial or PA pressure
2. There are QRS complexes with the same R–R intervals as the patient’s baseline rhythm evident in any ECG lead
throughout the alarm event
3. Good quality SpO2 signal has pulsatile waveform that matches rate of underlying baseline rhythm
4. VFIB/VTAC alarm duration is .60 seconds but there is no EMR documentation that it was recognized clinically
(syncope, seizure, loss of consciousness, cardiac arrest)
3. ACC VENT $6 ventricular beats
with HR 50–100 bpm
Proof of True Positive:
1. Wide QRS beats are not preceded by a P wave with a consistent PR interval
2. Fusion beats are evident at the transition between ventricular rhythm and sinus rhythm
Proof of False Positive: (either #1 or #2 confirms false positive alarm)
1. Event is sinus rhythm with BBB (P waves prior to each wide beat with consistent PR interval)
2. Patient is known to have ventricular pacemaker; event QRS matches paced rhythm on standard ‘‘diagnostic’’ 12-lead
ECG
4. VTACH $6 consecutive PVCs
with rate $100 bpm
Proof of True Positive: (any of the following confirms true positive alarm)
1. Simultaneous drop in invasive arterial or PA pressure
2. Documentation from EMR of VT at same time; standard 12-lead ECG documentation of VT read by cardiologist
3. Atrioventricular (AV) dissociation is evident throughout the wide QRS tachycardia in any ECG lead
4. Event wide QRS morphology is different than patient’s baseline rhythm with BBB
Proof of False Positive: (any of the following confirms false positive alarm)
1. No simultaneous change in invasive arterial or PA pressure (if it is ‘‘slow’’ VT with rate 100–150, there will be less
decrease in pressure waveform amplitude)
2. There are QRS complexes with the same R–R intervals as the patient’s baseline rhythm evident in any ECG lead
throughout the alarm event
3. Good quality SpO2 signal has pulsatile waveform that matches rate of underlying baseline rhythm
4. VTACH alarm duration is .60 seconds but there is no EMR documentation that it was recognized clinically (syncope,
seizure, loss of consciousness, cardiac arrest)
5. Event has the same wide QRS complex morphology in all 7 ECG leads as the patient’s baseline rhythm with right or left
BBB; additional confirmation if sinus P waves are evident prior to each QRS or the rhythm has no discernable P waves but
is randomly irregular indicating atrial fibrillation
6. Event is due to intermittent ventricular pacing (visible pacer spikes before each wide QRS or QRS in all 7 leads matches
a standard ‘‘diagnostic’’ 12-lead ECG acquired during ventricular pacing)
5. PAUSE 3-second interval without
a QRS complex
Proof of True Positive: (either #1 or #2 confirms true alarm)
1. Simultaneous pause on invasive arterial or PA waveform
2. Simultaneous pause on good quality SpO2 waveform
Proof of False Positive: (any of the following confirms false positive alarm)
1. No simultaneous pause in invasive arterial or PA pressure
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technical alarms. UCSF’s default settings restrict the number of
alarms that generate an audible tone to just those that are
considered clinically important. Despite this restriction, there were
a total of 381,560 audible alarms, for an average alarm burden of
187 audible alarms per bed per day.
Table 3. Cont.
Alarm Label & Algorithm Definition Proof of True versus False Alarm by Investigator
2. No simultaneous pause on good quality SpO2 waveform
3. There is a visible QRS during the pause (may be low amplitude) in any of the 7 available leads
6. VBRADY $3 consecutive
ventricular beats with HR #50 bpm
Proof of True Positive:
1. Rhythm is complete heart block with ventricular escape rhythm
2. Rhythm is sinus node arrest with ventricular escape rhythm
Proof of False Positive: (either #1 or #2 confirms false positive alarm)
1. Event is sinus bradycardia with BBB (P waves prior to each beat with consistent PR interval)
2. Patient is known to have pacemaker; event QRS in all 7 leads matches paced rhythm on ‘‘diagnostic’’ 12-lead ECG
doi:10.1371/journal.pone.0110274.t003
Figure 4. True positive ventricular tachycardia alarm using seven available ECG leads for diagnosis. Page one of the alarm annotation
analysis tool shows a 10-second rhythm strip of all seven available ECG leads at the time that a ventricular tachycardia alarm was triggered. In this and
subsequent Figures, ECG Leads are displayed from top to bottom in the following sequence: Lead I, II, III, V (typically V1), aVR, aVL, aVF. As evident at
the beginning of the rhythm strip, the patient has an underlying rhythm of atrial fibrillation with a rapid ventricular rate of about 140. There is an
isolated ventricular premature beat (4th beat from the end) and its QRS morphology is identical to the initial beat of the alarm event. Knowing that
the event is initiated by a ventricular ectopic beat provides strong evidence that this event is a true ventricular tachycardia alarm.
doi:10.1371/journal.pone.0110274.g004
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Most Frequently-Occurring Alarms
When looking at all audible and inaudible alarm categories
(Figure 8), the alarm group that out-numbered all other alarm
categories was premature ventricular contractions (PVCs) with a
total of 854,901 PVC alarms during the 31-day period. The next
most prevalent alarm group was technical alarms. A majority
(79.4%) of the technical alarms were inaudible text message alarms
(Artifact. 538,277; single Lead Fail, 90,547). Other frequent
alarms were vital sign parameter threshold violations with the four
most prevalent being: heart rate, invasive arterial blood pressure,
respiratory rate/apnea, and SpO2.
Next to PVCs, atrial fibrillation was the second most frequently-
occurring arrhythmia alarm. Repetitive atrial fibrillation alarms
occurred in patients with persistent atrial fibrillation. For example,
one patient with persistent atrial fibrillation generated 15,296
atrial fibrillation alarms and an additional 15,433 high heart rate
alarms. The reason for the numerous high heart rate alarms was
that this patient’s ventricular rate in atrial fibrillation averaged
130–135 which exceeded the hospital default high heart rate alarm
threshold of 130. In this patient, the nurse did not tailor the alarm
settings to reduce alarm burden. For example, the atrial fibrillation
alarm could have been changed from an Advisory alarm to an
inaudible Message alarm; the high heart rate threshold could have
been increased to 150. The result of not tailoring alarm
parameters to this individual patient was an average of 211
alarms per hour over the patient’s 6-day ICU stay.
Frequency of ‘‘Treatable’’ Ventricular Arrhythmia Alarms
The practice guideline for treatment of patients with ventricular
arrhythmias states that neither accelerated ventricular rhythm nor
non-sustained ventricular tachycardia lasting less than 30 seconds
warrant antiarrhythmic therapy in the hospital setting [5]. A total
of 4,361 accelerated ventricular alarms occurred in the 31-day
study period, all of which sounded an audible alarm because the
hospital default setting was configured to be audible (Warning) for
this alarm. Since no treatment is indicated for accelerated
ventricular rhythm, all these audible alarms could be considered
‘‘nuisance’’ alarms because they are not ‘‘actionable.’’
To answer the question about how many ventricular tachycar-
dia alarms were actionable, we determined how many true
ventricular tachycardia alarm events lasted 30 seconds or longer.
There were a total of 502 ventricular tachycardia alarms that were
determined to be true positives. Of these, 334 occurred in one
patient with ‘‘ventricular storm’’ whose implantable device readily
terminated each arrhythmia event. Excluding this one patient with
device-terminated ventricular tachycardia, there were 168 true
positive ventricular tachycardia alarms. Of these, 25 (14.9%) were
sustained for 10 seconds or longer and 12 (7.1%) were sustained
Figure 5. True positive ventricular tachycardia alarm using non-ECG waveforms for diagnosis. Page 2 of the alarm annotation analysis
tool depicts the same alarm event as in Figure 4 with all available non-ECG waveforms. Additional proof that this is a true ventricular tachycardia
alarm is provided by observing cessation of the arterial blood pressure waveform that falls to near zero during the arrhythmia.
doi:10.1371/journal.pone.0110274.g005
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for 30 seconds or longer. All 12 of these alarms that persisted for
30 seconds or longer were life-threatening events that occurred in
6 patients. Three patients had ‘‘do not resuscitate’’ orders and all 3
died; the remaining 3 patients had full resuscitation attempts with
2 patients dying and one who survived to hospital discharge.
Frequency of Respiratory Rate (RR) and Apnea Alarms
There was a total of 161,931 apnea or respiratory rate
parameter alarms in the five ICUs over the 31-day period
(average, 79 alarms/bed/day). Although apnea alarms were not
annotated by the investigators, the respiratory waveform observed
during arrhythmia alarm annotation often had a flat line
appearance (Figure 9) in patients who were known to be breathing
adequately (i.e., no respiratory arrest/need for intubation or
breathing with mechanical ventilation).
Frequency of ST-segment Monitoring Alarms
The overall frequency of ST alarms was less because only one of
the five ICUs uses the ST-segment monitoring feature. In that 16-
bed cardiac ICU, there was an average of 200 ST alarms per day
despite a wide alarm threshold setting requiring a change in ST
amplitude of 62 millimeters for triggering an alarm. The ECG
criterion for transient myocardial ischemia is a 1 millimeter ST
amplitude change lasting for at least one minute [6]. As shown in
Table 5, only a small proportion (9%) of the total 6,196 ST alarm
events persisted for more than one minute; 91% could be
considered non-actionable or nuisance alarms.
Alarm Accuracy
Six arrhythmia alarms that were audible according to the adult
ICU hospital default settings were annotated including asystole,
ventricular fibrillation, ventricular tachycardia, accelerated ven-
tricular rhythm, pause, and ventricular bradycardia. The accuracy
of these alarms is shown in Table 6. Of the 461 patients, 250
patients generated at least one of the six alarm types for a total of
12,671 alarms for annotation. Only 15 (0.11%) alarms could not
be determined as true versus false positives by the investigators.
Although an invasive arterial pressure waveform was present in
28% and a SpO2 waveform was present in 96% of the alarm
annotations, very few alarms required non-ECG waveforms to
Figure 6. False positive ventricular tachycardia alarm using seven available ECG leads for diagnosis. Page one of the alarm annotation
analysis tool in a second patient with a ventricular tachycardia alarm. Proof that this is a false positive alarm is provided by observing Lead III that
shows clearly-visible P-QRS-T waveforms indicating normal sinus rhythm. All six remaining ECG leads show artifact that mimics ventricular
tachycardia. It is important to point out that Lead III is not one of the two leads routinely displayed on the bedside monitor in our ICUs so unless all
available leads are reviewed, a misdiagnosis would be made of rapid polymorphic ventricular tachycardia. This type of rapid, repetitive artifact on the
ECG is often created during patient monitoring by motion artifact during activities of daily living. The non-artifact lead (Lead III) uses the left arm and
left leg electrodes but not the right arm electrode. So, this is likely to be a right-handed patient doing something like brushing teeth.
doi:10.1371/journal.pone.0110274.g006
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diagnose. In fact, 11,852 of the total 12,671 alarms (94%) could be
diagnosed from analysis of the seven available ECG leads.
Accuracy of Ventricular Tachycardia and Ventricular
Fibrillation Alarms. What was critical for the diagnosis of
ventricular tachy-arrhythmia alarms was the visualization of all
seven ECG leads because, not uncommonly, artifact mimicking a
ventricular arrhythmia contaminated all but one lead and without
observing this non-artifact lead, a misdiagnosis would have been
likely (see Figure 6). Of the 51 cases of false positive ventricular
fibrillation alarms, 8 (16%) had a single non-artifact ECG lead
visible to identify artifact mimicking ventricular fibrillation
(Figure 10). Of importance, the single non-artifact lead was often
not being displayed at the bedside or central station monitors so a
misdiagnosis was likely unless the clinician took the time to print
out the alarm event in all seven ECG leads.
Accuracy of Accelerated Ventricular Rhythm
Alarms. Accelerated ventricular rhythm alarms were false in
94.8% of the 4,361 cases. A common finding in these false alarm
cases was that the patient had a wide QRS complex due to a pre-
existing right or left bundle branch block (Figure 11). In
annotating the 4,361 accelerated ventricular rhythm alarms, we
often observed in patients with concomitant invasive arterial
pressure waveforms that this rhythm was not hemodynamically
significant (Figure 12). Moreover, not a single accelerated
ventricular rhythm alarm was associated with a Code Blue event.
Another cause of false accelerated ventricular rhythm alarms
was intermittent ventricular pacemaker rhythm (Figure 13). The
monitor manufacturer requires the user to activate a feature called
‘‘PaceMode’’ for all patients with ventricular pacemakers.
Activation of the PaceMode feature changes the frequency setting
the algorithm uses to detect high frequency pacemaker stimuli
(pacer ‘‘spikes’’). When pacemaker stimuli are sensed by the
arrhythmia algorithm, an artificial spike is ‘‘painted’’ in for
clinicians to readily identify pacing rhythm. We found that only
33.3% of patients with pacemakers had the PaceMode feature
activated.
Accuracy of Brady-Arrhythmia Alarms. A serendipitous
discovery during arrhythmia alarm annotation was that patients
who had low amplitude QRS complexes, especially in the limb
leads, had a lot of false brady-arrhythmia alarms (asystole, pause,
ventricular bradycardia). Figure 14 shows the hospital-acquired
standard ‘‘diagnostic’’ 12-lead ECG of the patient who contrib-
uted the most alarms for annotation. This one patient contributed
5,725 of the 12,671 arrhythmia alarms for annotation (45.2%).
Figure 7. False positive ventricular tachycardia alarm using non-ECG waveforms for diagnosis. Page 2 of the alarm annotation analysis
tool depicts the same alarm event as in Figure 6 showing all available non-ECG waveforms. Additional proof that this is a false ventricular tachycardia
alarm is provided by the following: a.) no change in the arterial pressure waveform during the event, b.) arterial waveform pulsations match the
normal sinus rhythm rate, and c.) SpO2 waveform pulsations match the normal sinus rhythm rate. Of interest, the same artifact that contaminates the
ECG signal also contaminates the respiratory waveform, as evidenced by an erroneous device-measured respiratory rate of 162 breaths per minute.
doi:10.1371/journal.pone.0110274.g007
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Table 4. Schema for Counting and Reporting Physiologic Monitor Device Alarms.
Arrhythmia Alarms
Alarm Condition Short Label Definition
1. Accelerated Ventricular Rhythm Acc Vent $6 ventricular beats with heart rate between 50-100
2. Atrial Fibrillation Afib Irregular timing of QRS complexes and absence
of preceding P waves
3. Asystole Asystole Heart rate drops to zero; typically no QRS for 5–6 seconds
4. Pause Pause No QRS for a 3-second interval
5. Ventricular Bradycardia V Brady $3 consecutive ventricular beats at an average rate #50
6. Ventricular Fibrillation Vfib/Vtac Course flutter waves without QRS complexes
7. Ventricular Tachycardia Vtach $6 consecutive ventricular beats at rate $100
8. Premature Ventricular
Contractions
All PVC VT.2 3-5 consecutive ventricular beats at rate $100
PVC Isolated PVCs
R on T PVC falls on the ST or T wave portion
of previous beat
Couplet Two consecutive PVCs with rate .100
Bigeminy PVC alternates with a non-ventricular beat for $3 cycles
Trigeminy PVC alternates with 2 non-ventricular beats for $3 cycles
PVC = . X PVC count is equal to or.than user-defined limit
Parameter Alarms (‘‘Too Low – Too High’’ Vital Sign Measurements)
9. Heart Rate All HR HR,or.user-defined limit determined from ECG waveform (HR)
HR,or.user-defined limit determined from SpO2 waveform (SpO2 Rate)
HR,or.user-defined limit determined from arterial pressure
waveform (ART Rate or FEM Rate)
Bradycardia arrhythmia alarm: 8 R–R intervals fall below user-defined
low HR limit setting
Tachycardia arrhythmia alarm: 8 R–R intervals occur above
user-defined high HR limit setting
10. Respiratory Rate All RR Respiratory rate,or.user-defined limit
No breaths detected for user-defined period of seconds (Apnea Alarm)
11. Oxygen Saturation All SpO2 SpO2, or.user-defined limit determined from pulse oximetry sensor
12. Invasive Arterial Pressure All ART Systolic = or,or.user-defined limit
Diastolic = or,or.user-defined limit
Mean = or,or.user-defined limit
13. Noninvasive Blood Pressure All NIBP Systolic = or,or.user-defined limit
Diastolic = or,or.user-defined limit
Mean = or,or.user-defined limit




Systolic = or,or.user-defined limit for CVP, RAP, PAP, LAP
Diastolic = or,or.user-defined limit for CVP, RAP, PAP, LAP
Mean = or,or.user-defined limit for CVP, RAP, PAP, LAP
15. Intra-cranial Pressure All ICP ICP mean = or,or.user-defined limit
16. ST-segment Amplitude All ST Lead I or II or III or aVR or aVL or aVF or V1 or V2 or V3 or V4 or V5 or V6 ST,
or.
than PR segment amplitude by user-defined
setting (hospital default, 62 millimeters)
Technical Alarms
17. Problem with artifact, sensors,
probes, line disconnects, etc.
All Technical Artifact: noisy signal on ECG
Arrhythmia suspend: no arrhythmia detection due to sustained artifact
Arrhythmia Off
ECG Leads Fail or No ECG or individual Lead Fail (I, II, III, RL, V)
Respiratory Lead Fail
Sensor Fail for ART or FEM or ICP or CVP or RAP or PAP or LAP
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Although this patient’s QRS amplitude was low in the six limb
leads, the V lead had adequate amplitude for an algorithm to
sense. Therefore, if the arrhythmia algorithm had used all
available leads to identify QRS complexes, the problem of
under-counting heart rate and false brady-arrhythmia alarms
could have been avoided.
Table 7 shows an analysis of how many asystole or pause false
alarms had visible QRS complexes in at least one of the available
ECG leads. The vast majority of these false alarms (91% of false
asystole alarms; 94% of false pause alarms) had visible QRS
complexes in one or more leads that could have been detected by
the arrhythmia algorithm had all available leads been used.
Effect of Signal Quality on False Arrhythmia Alarm Rate
A majority (74.9%) of the annotated arrhythmia alarms were
rated by the investigators as having good signal quality at the time
the alarm was triggered (Figure 15). Only 8.5% of alarms had
poor signal quality. False alarms had a higher proportion of poor
signal quality (9.3%) compared with true alarms (0.9%); however,
our findings indicate that poor signal quality was not a major cause
of the excessive number of arrhythmia alarms. In rare instances,
there was clear-cut evidence of an electrode problem triggering a
false alarm as shown in Figure16.
Discussion
The present study represents the largest (N = 12,671) annotated
arrhythmia alarm database to date from all consecutive patients
treated in full service hospital adult ICUs. The only comparable
database is the arrhythmia alarm annotation subset from the
Multiparameter Intelligent Monitoring in Intensive Care (MIMIC
II) database [7] (see Table 8 for a comparison). The MIMCI II
investigators reported an alarm burden of 48 alarms per bed per
day [8] which is lower than our audible alarm burden of 187
alarms per bed per day. A likely explanation for this difference is
Table 4. Cont.
Arrhythmia Alarms
Alarm Condition Short Label Definition
SpO2 :Probe Off or Probe Fail or Low Signal or Incompatible
Cable or Connect Probe
Noninvasive BP: invalid command or Excessive
Pressure 200 or Exceeded 3 min or Deflation Failure or
Inflation Time Exceeded
Line Disconnect for PA or ART or FEM or CVP
CVP = central venous pressure; RAP = right atrial pressure; PAP = pulmonary artery pressure; LAP = left atrial pressure; ART = invasive arterial line; FEM = invasive arterial
line in femoral site.
doi:10.1371/journal.pone.0110274.t004
Figure 8. Frequency of all unique alarms (N = 2,558,760) over a 31-day period.
doi:10.1371/journal.pone.0110274.g008
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that the alarms annotated in the MIMIC II database included only
patients who had invasive arterial pressure monitoring. This selects
for a more sedentary sample because patients with arterial
pressure monitoring are sedated so they don’t inadvertently
disconnect their arterial line and hemorrhage to death. Therefore,
the MIMIC II ECG waveforms would not be expected to contain
as much motion artifact triggering alarms as in our ‘‘real world’’
database.
We found a staggering total number of alarms (.2,500,000 in
one month) when counting all audible and inaudible arrhythmia,
parameter, and technical alarms. Although many of these alarms
were configured to be inaudible text messages, we still found a
high audible alarm burden of 187 audible alarms per bed per day.
A noisy alarm environment interrupts patients’ sleep and invokes
fear in patients and their families. In our institution, the question
on our patient satisfaction questionnaire that consistently has a low
score is the one related to hospital noise.
The most prevalent group of alarms was PVC alarms that were
triggered nearly 900,000 times over the one-month period. When
hospital monitoring began in the late 1960’s, PVC’s were thought
to lead to ventricular tachycardia or fibrillation. As a result,
standing orders were established in Coronary Care Units for
nurses to initiate intravenous antiarrhythmic therapy for condi-
tions such as 5 or more PVC’s per minute, a ventricular couplet, a
Figure 9. False apnea alarm in a patient breathing adequately on mechanical ventilation. The respiratory waveform (bottom tracing
labelled ‘‘Resp’’) has a flat line appearance. The detection of respirations from the ECG lead (impedance method) is inaccurate in this patient,
displaying an erroneous respiratory rate of 4 per minute.
doi:10.1371/journal.pone.0110274.g009
Table 5. ST-Segment Alarm Durations in a 16-Bed Cardiac ICU.
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single PVC with ‘‘R on T’’ phenomenon, multiform PVC’s,
ventricular bigeminy or trigeminy, or 3–5 consecutive PVC’s.
Therefore, PVC alarm algorithms were developed to identify
patients for whom treatment was recommended. However,
treatment of PVC’s changed when a landmark clinical trial, the
Cardiac Arrhythmia Suppression Trial (CAST) was published in
1989 [9]. The CAST study demonstrated that antiarrhythmic
therapy was associated with more deaths than placebo. Thus, in
the 25 years since the CAST report, PVCs have been considered a
non-actionable alarm.
In our institution, PVC alarms are configured to be inaudible.
However, there is a concern about missing patients who are at risk
for the potentially lethal arrhythmia, torsade de pointes. In
patients who develop a prolonged QT interval due to the initiation












1. Asystole 792 113 260 531 67.0%
2. Ventricular Fibrillation 158 19 107 51 32.3%
3. Ventricular Tachycardia 3861 183 502 3352 86.8%
4. Accelerated Ventricular Rhythm 4361 99 224 4135 94.8%
5. Pause 2239 140 272 1963 87.7%
6. Ventricular Bradycardia 1260 39 40 1219 96.7%
TOTAL 12671* 1405 11251 88.8%
*15 alarms were indistinguishable: 1 Asystole, 7 VTach, 2 AccVent, 4 Pause, and 1 Ventricular Brady.
doi:10.1371/journal.pone.0110274.t006
Figure 10. False alarm with one non-artifact ECG lead that confirms artifact mimicking ventricular fibrillation. Six of the seven ECG
leads show what looks like a rapid (.400) polymorphic ventricular arrhythmia. However, Lead II clearly shows sinus rhythm at a rate of 94. Without
this single non-artifact lead, a misdiagnosis would be made of ventricular fibrillation.
doi:10.1371/journal.pone.0110274.g010
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of a potentially proarrhythmic drug, the onset of PVC’s and
ventricular couplets may be a sign of impending torsade de pointes
[10]. For this reason, a smart alarm that would couple continuous
QTC measurement with the development of PVC’s would be
beneficial to warn clinicians when a QT-prolonging drug should
be discontinued to prevent torsade de pointes.
Consecutive PVCs (non-sustained ventricular tachycardia) is an
arrhythmia that is often of little consequence to the patient if the
rate is not excessively rapid (,140) or its duration is brief.
Published practice guidelines state that only symptomatic and
sustained ($30 seconds) ventricular tachycardia should be treated
in the hospital setting [5]. We found that of 168 true instances of
ventricular tachycardia, only 25 (14.9%) were sustained for 10
seconds or more and only 12 (7.1%) lasted 30 seconds or more.
However, all 12 of the 30-second episodes were cardiac arrest
events so an arrhythmia algorithm that required the patient to be
in ventricular tachycardia for $30 seconds before triggering an
alarm would be too extreme. At our institution, the Director of the
Cardiac Electrophysiology Service wants non-sustained ventricular
tachycardia lasting $10 seconds to trigger an alarm and to be
documented in the medical record whether or not the arrhythmia
is treated (personal communication, Edward P. Gerstenfeld, MD
on June 13, 2014). As a result of our findings and in accordance
with the practice guideline that states that in-hospital treatment of
non-sustained ventricular tachycardia is unwarranted, our institu-
tion has changed the hospital default setting to make VT .2
alarms (3–5 consecutive PVC’s) inaudible text messages.
It would be helpful if device manufacturers made ventricular
tachycardia alarms configurable. The result of configuring
ventricular tachycardia alarms to those lasting $10 seconds in
the present study would have been a reduction of ventricular
tachycardia true alarms by 85%. Moreover, the reduced number
of these alarms would have been considered clinically actionable
for either documentation in the medical record or antiarrhythmic
treatment. In addition, smarter alarms should be developed and
tested to identify which ventricular tachycardia events are likely to
be symptomatic (e.g., those with rates .140 that decrease arterial
pressure).
The second most prevalent alarm category was technical alarms
that is in agreement with the study by Siebig and colleagues [11]
who reported technical alarms to be their second most common
type of alarm. It is important to point out that nearly 80% of our
technical alarms were inaudible text message alarms (Artifact and
single Lead Fail alarms). Inaudible text message alarms should not
be considered totally innocent in causing alarm fatigue because
they often alert about a problem the nurse doesn’t know how to
solve which may cause anxiety. For example, if the bedside
monitor displays the message ‘‘Lead I Fail’’, few nurses know that
Figure 11. False accelerated ventricular rhythm alarm in a patient with left bundle branch block. Sinus rhythm at a rate in the 609s is
evident by observing P waves preceding each QRS complex with a consistent PR interval. P waves are visible in all seven leads (especially clear-cut in
Leads I and II).
doi:10.1371/journal.pone.0110274.g011
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they need to check the integrity of two electrodes used to make
Lead I: the right and left arm electrodes. In contrast, if the monitor
displays the message ‘‘Lead V Fail’’, the integrity of all five
electrodes should be checked. What would be more helpful is an
algorithm that would monitor each electrode’s impedance and
provide a message to check a specific electrode (RA, LA, RL, LL,
or V).
It is unclear whether the high number of technical alarms we
observed means we have a problem with electrode integrity and
signal quality in our ICUs. No other study has reported on the
prevalence of technical (especially inaudible message) alarms so we
have no source for comparison. Most of our technical alarms
(79.4%) were inaudible Artifact or single Lead Fail alarms that
may be harbingers of more serious audible alarms or subsequent
complete arrhythmia suspension.
It has been suggested that alarm burden could be reduced if
nurses applied fresh electrodes every 24 hours [12]. It would be
interesting to determine whether preventive action (electrode
change) taken during the text message phase of technical alarms
would reduce subsequent audible alarms and arrhythmia suspen-
sion. However, Artifact or single Lead Fail alarms could also be
caused by motion artifact in a patient with intact electrodes. A
brief period of motion artifact in an otherwise good signal quality
ECG appeared to be the cause of many of our false arrhythmia
alarms (see Figures 6 and 7). Obviously, an optimal electrode
product, skin prep, and daily change regimen will not impact
alarm fatigue if the source of technical and false arrhythmia alarms
are due to normal patient movement.
A surprising finding was that poor signal quality was not a major
cause of false arrhythmia alarms. For example, only 9% of the
11,251 false arrhythmia alarms were rated by the investigators as
having poor signal quality.
Our findings confirm that nurses do not always tailor alarm
settings appropriately for their individual patient. We found that
hospital default settings were often left in place regardless of
whether it made sense for the individual patient. While it is
tempting to blame the user for alarm fatigue, device manufacturers
also have a responsibility to make monitors more helpful,
interactive, and intuitive. Moreover, it would be more efficient
and reliable to have monitor devices suggest alarm setting changes
rather than to rely on humans, who are distracted by multiple
competing priorities, to remember to tailor alarms to their
individual patient.
A major opportunity exists for monitor device manufacturers to
track frequent repetitive alarms and to remind nurses to consider
changing alarm settings. For example, if the hospital default setting
Figure 12. True accelerated ventricular rhythm alarm showing why this arrhythmia is not considered an ‘‘actionable’’ alarm
condition. Accelerated ventricular rhythm at a rate of 56 for the first 5 beats followed by 2 fusion beats; the last 2 beats are normal sinus rhythm.
The invasive arterial pressure waveform (bottom tracing) shows no change between normal rhythm and accelerated ventricular rhythm which
confirms the rationale for the published guidelines stating no treatment is indicated for this arrhythmia in hospital settings [5].
doi:10.1371/journal.pone.0110274.g012
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for high heart rate is 130 but the patient’s rate averages 135
because of persistent atrial fibrillation, a prompt could pop up
saying, ‘‘Mean HR 135; do you want to increase high HR setting?’’
A drop-down menu of rates beginning at 136 could then be
provided to quickly change the threshold and reduce subsequent
alarms. Then, when treatment of rapid ventricular rate is
successful in lowering this patient’s rate, another prompt could
say, ‘‘Mean HR 90; do you want to restore hospital default setting
of 130?’’.
Burgess, et al. examined heart rate (HR) and respiratory rate
(RR) settings in 317 patients who had no adverse hospital events to
determine ideal settings to minimize nuisance alarms [13]. They
reported that a high HR of 130–135, low HR of 40–45, high RR
of 30–35, and low RR of 7–8 were optimal for this stable cohort.
While such analyses may provide guidance for hospital default
settings, a ‘‘one size fits all’’ approach is inappropriate because of
large variations between individual patient’s vital sign measure-
ments. We believe parameter threshold settings should be tailored
to the individual patient for maximal reduction of nuisance alarms.
In clinical practice, it is important to detect when patients
develop atrial fibrillation so the nurse can assess how the patient is
tolerating the arrhythmia and prompt treatment can be initiated to
slow the ventricular rate and restore sinus rhythm. Likewise, it is
important to detect when atrial fibrillation terminates because
patients should be assessed for embolic events (stroke, peripheral
arterial emboli) at the time of cardioversion. Thus, a monitor
alarm at atrial fibrillation onset and termination would be
clinically useful. However, it is not necessary to have repetitive
atrial fibrillation alarms for patients with persistent atrial
fibrillation when treatment has already been initiated or for
patients with permanent (chronic) atrial fibrillation where the goal
is not to terminate the arrhythmia. In such cases, a prompt could
pop up saying, ‘‘Do you want to continue to hear atrial fibrillation
alarms?’’ If the nurse replied ‘‘no’’, then the alarm could
automatically be switched to an inaudible text message.
A feature the device manufacturers should provide to help
clinicians diagnose arrhythmia alarms more accurately is to make
it easy (‘‘one step’’) to visualize and print out all available ECG
leads at the time an arrhythmia alarm is triggered. We found that
we could diagnose whether an arrhythmia alarm was true or false
in 94% of the 12,671 cases by observing the seven available ECG
leads; we rarely needed additional non-ECG waveforms (e.g.,
Figure 13. False accelerated ventricular rhythm alarm in a patient with ventricular pacing. Patient with atrial fibrillation and intermittent
ventricular pacing does not have PaceMode activated. As a result, a period of ventricular pacing goes undetected by the algorithm (no pacemaker
spikes are ‘‘painted’’ in) and a false alarm is generated of accelerated ventricular rhythm. The investigators determined this to be intermittent pacing
(rather than accelerated ventricular rhythm) because the rate matched the pacemaker heart rate setting. Moreover, the QRS morphology across all 7
leads matched the QRS morphology of corresponding leads on a hospital-acquired standard ‘‘diagnostic’’ 12-lead ECG during a known period of
pacing.
doi:10.1371/journal.pone.0110274.g013
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arterial pressure or SpO2 waveforms) to reach a diagnosis. Not
uncommonly, false ventricular arrhythmia alarms were triggered
by artifact that contaminated all but one ECG lead and this lead
was often not a lead being displayed at the bedside or central
station.
Likewise, if the arrhythmia algorithm took advantage of all
available leads, it is likely that the high false alarm rate could be
significantly reduced. If only one alarm in 10 is a true arrhythmia,
it is not surprising that this ‘‘cry wolf’’ phenomenon results in staff
ignoring alarms. If, however, the arrhythmia algorithm could
identify a non-artifact lead for analysis and reduce the false alarm
rate, clinicians would rapidly perceive that alarms were clinically
meaningful and respond accordingly.
An additional condition triggering false alarms that could be
mitigated by an analysis of all available ECG leads is the problem
of low QRS amplitude. Low amplitude QRS complexes can occur
in the morbidly obese, patients with pericardial effusions, and
altered conduction such as bundle branch block. The outlier
patient in the present study who generated more arrhythmia
alarms for annotation than any other patient (45% of the total
12,671 annotated alarms) had low amplitude QRS complexes in
the limb, but not precordial leads due to left bundle branch block.
The American National Standard for cardiac monitors, heart
rate meters and alarms [14] states that the device should not detect
a QRS if the waveform is less than 0.15 mV (1.5 millimeters) in
size. This standard was designed to prevent the monitor from
misdiagnosing P waves as QRS complexes during ventricular
standstill. However, monitor manufacturers elect to use a higher
QRS detection threshold (e.g., 0.5 mV) and they also may require
that this higher threshold be present in more than one ECG lead.
In addition, the device may measure only the portion of the QRS
complex that points in one direction rather than measuring from
‘‘peak to trough’’ as the National Standard recommends. This
results in undercounting of amplitude in biphasic QRS complexes.
All of these measurement decisions result in heart rate under-
counting and false asystole, pause, and bradycardia alarms.
Failure to detect low amplitude QRS complexes is probably a
systemic problem with monitor manufacturers. For example,
investigators in the MIMIC II trial (Philips monitor devices)
reported an even higher false alarm rate for asystole (90.7%) [7]
than our current findings with GE monitor devices (false asystole
alarms, 67%).
We found that when we observed all seven available ECG leads,
a sizable QRS complex was readily visible in one or more lead in
91% of the false asystole alarms and in 94% of the false pause
Figure 14. Low amplitude QRS in a patient with an excessive number of alarms. Standard ‘‘diagnostic’’ 12-lead ECG recorded from the
patient who contributed nearly half of the 12,671 arrhythmia alarms for annotation. The ECG shows left bundle branch block with low amplitude QRS
complexes in the limb leads but not in the V leads. Since one of the available leads acquired with the physiologic patient monitoring device is a V
lead, the arrhythmia algorithm could have avoided the excessive number of false alarms had all available leads been used for QRS detection.
doi:10.1371/journal.pone.0110274.g014
Table 7. Frequency of Visible QRS Complexes in One or More ECG Leads during False Brady-Arrhythmia Alarms.
Alarm Type Visible QRS Complex
Yes No
False Asystole Alarms, N = 518 469 (91%) 49 (9%)
False Pause Alarms, N = 1903 1786 (94%) 117 (6%)
doi:10.1371/journal.pone.0110274.t007
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alarms. An alternative approach that would reduce false alarms
would be to count waveforms as small as 0.15 mV from peak to
trough as QRS complexes, especially if they match the pulsatile
rate of SpO2 or arterial pressure waveforms.
One arrhythmia alarm that generated a lot of false alarms (95%
false) but did not cause a drop in arterial pressure or cardiac arrest
was accelerated ventricular rhythm. It is not surprising that a
ventricular rhythm at a rate of 50–100 would be well tolerated by
the patient because this arrhythmia is analogous to ventricular
pacing in this rate range. As a result of our findings and in
accordance with the practice guideline that states that in-hospital
treatment of accelerated ventricular rhythm is unwarranted [5],
our institution has changed the hospital default setting to make
accelerated ventricular rhythm alarms inaudible text messages.
This change alone is anticipated to eliminate more than 4,000
audible alarms per month in our adult ICU’s.
Whalen, et al. took a completely different approach to
accelerated ventricular rhythm alarms in their Quality Improve-
ment Project by configuring them to the highest level of crisis
alarms [15]. Their rationale was to ‘‘ensure that nursing staff
viewed these alarms as they occurred.’’ ([15], page 4) However, it
is unclear why staff should be bothered by a noxious audible alarm
for an arrhythmia event that is well tolerated by the patient and
does not warrant treatment according to published practice
guidelines [5].
Patients with intermittent ventricular pacing often trigger false
ventricular alarms, especially when the nurse has neglected to
activate the PaceMode feature that the device requires to detect
high frequency pacemaker stimuli (pacer ‘‘spikes’’). We found that
only one third of patients who had pacemakers had the PaceMode
feature activated. This provides another opportunity for the device
manufacturer to search for pacer spikes in all patients so that we
are not dependent upon humans to remember to activate this
feature.
Although respiratory waveform annotation was not performed
in our study, anecdotal evidence of flat-line respiratory waveforms
in patients we knew were on mechanical ventilation or breathing
normally suggests a problem with detection of respiration using
impedance methods. Manual searching by the user for the best
respiratory ECG lead is a time-consuming and often neglected
task. Thus, it would be beneficial for the monitor device to help
the user by automatically searching for the best available ECG
lead for a respiratory waveform of adequate size for detection. An
area for future research is to develop and test other, and perhaps
more accurate, measures of respiratory rate and apnea detection
such as those derived from subtle QRS morphology changes with
inspiration and expiration [16].
Two parameter alarms that lend themselves to adding delays
before an alarm is triggered are SpO2 and ST-segment alarms.
For both of these parameters, brief spikes in the trend are not
indicative of a pathophysiologic process. Welch [17] reported that
increasing alarm delays from 5 to 15 seconds could decrease
alarms by 70%. However, this was an off-line retrospective
analysis with no data collected on what effect this alarm delay
might have on patient outcomes. We are currently completing a
prospective, randomized clinical trial to test whether the addition
of a SpO2 alarm delay of 20 seconds plus a change of SpO2 default
threshold from 90% to 88% will reduce SpO2 alarm burden
without causing adverse patient outcomes.
In terms of ST-segment monitor alarms, we found that the vast
majority (91%) of these alarms represented brief spikes of ST
amplitude change rather than the gradual ST change that is
indicative of transient myocardial ischemia. We previously
reported that the most frequent cause of false ST-segment monitor
alarms is a body position change that typically causes a quick
change in ST amplitude [18]. Therefore, ST alarms should be
configurable so a one-minute delay could be set for ST segment
changes in accordance with the Holter guideline criteria for the
diagnosis of transient myocardial ischemia [6]. In addition, acute
myocardial ischemia produces ST changes in at least two
Figure 15. ECG signal quality in 12,671 annotated arrhythmia alarms. Good signal quality (green) was defined as a clearly visible P-QRS-T
waveform across all available leads with little to no noise, baseline wander, or leads off. Fair signal quality (yellow) was defined as moderate noise or
baseline wander but having identifiable QRS complexes for basic rhythm/rate detection. Poor signal quality (red) was defined as being unanalyzable
because of excessive noise, baseline wander or leads off.
doi:10.1371/journal.pone.0110274.g015
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Figure 16. Electrode failure causing artifact and a false ventricular tachycardia alarm. Electrocardiogram in 6 of the 7 available leads
shows intermittent loss of signal (signal ‘‘squares off’’ on top and bottom of tracing) due to an electrode problem such as loss of skin contact or dried
out electrode gel. One ECG lead (Lead II that uses the right arm and left leg electrodes) does not show electrode failure so the likely electrode that is
malfunctioning is the left arm electrode. Failure to apply fresh electrodes in this case will result in numerous false alarms.
doi:10.1371/journal.pone.0110274.g016
Table 8. Comparison of Annotated Arrhythmia Alarm ICU Databases.
Database Characteristics MIMIC II* UCSF
Monitor manufacturer Philips Healthcare GE Healthcare
Number, type of patients N = 447; had to have both ECG & invasive arterial pressure N = 461; all consecutive patients
Number, type of beds 48 beds; medical, surgical, cardiac 77 beds; medical, surgical, cardiac, neurologic
Total monitoring hours 41,301 hours 48,173 hours
Number, type of ECG leads 1–3 leads; inconsistent, including modified (MCL) leads 7 leads; consistently I, II, III, aVR, aVL, aVF, V1
Sampling rate 125 HZ ECG, 240 HZ; Pressures, 120 HZ; SpO2, 60 HZ
Resolution 8 bit 12 bit




Brady (,40), 717 Vbrady (#50), 1260
Tachy (.140), 1877 Accelerated ventricular rhythm, 4361
Pause, 2239
*Annotation subset of the MIMIC II database [7]. Vfib = ventricular fibrillation; Vtach = ventricular tachycardia; Brady = bradycardia; Tachy = tachycardia;
VBrady = ventricular bradycardia.
doi:10.1371/journal.pone.0110274.t008
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contiguous ECG leads [19]. As a result, requiring the ST change
to last at least one minute and to be present in two contiguous
leads would drastically reduce the number of false ST-segment
monitor alarms. Whereas contiguous precordial leads are gener-
ally not monitored in hospital settings, all six limb leads are
routinely available. Contiguity in the limb leads should be defined
as the following sequence: aVL, I, minus aVR, II, aVF, III [20].
Table 9 provides a summary of the conditions observed in the
present study that cause excessive physiologic monitor alarms. The
table also includes suggestions for device solutions.
Study Limitations
The focus of the present study was to gain insight into the cause
of excessive alarms, especially false alarms. We cannot report on
any false negatives that may have been missed in this cohort of
patients. However, we are confident that no lethal event was
missed by the monitor device because all of the 17 Code Blue
events were heralded with multiple arrhythmia and parameter
alarms.
Areas for future research
There is inadequate data on commercially-available electrodes
and how often they should be changed to prevent false alarms due
to electrode failure. It is also unknown what impedance
measurement would indicate electrode failure and how best to
measure impedance continuously. There is also insufficient data
on the best skin prep regimens that will decrease electrode
impedance without causing skin breakdown.
Investigators have reported that adding alarm delays for SpO2
[17] or other parameters (heart rate, respiratory rate, arterial and
noninvasive blood pressure) [21] would be effective in reducing
alarm fatigue. However, these studies have not measured the effect
of such delays on patient outcomes. Thus, future research is
required to determine whether these alarm delays are safe as well
as effective in reducing alarm burden.
Any algorithm change to incorporate recommendations in
Table 9 should be tested to determine the effect on false alarm
rates and identification of any unintended adverse consequences.
A ‘‘gold standard’’ database of annotated alarms should be made
available for such testing. Organizations like the Association for
the Advancement of Medical Instrumentation (AAMI), the U. S.
Food & Drug Association’s (FDA’s) Center for Radiological
Devices and Health, and the National Institutes of Health in
partnership with professional societies like the International
Society for Computerized Electrocardiology, the American
Association of Critical-Care Nurses, and the American Heart
Association could foster such a gold standard database.
In summary, the excessive number of physiologic monitor
device alarms is a complex interplay of inappropriate user settings,
patient conditions, and algorithm deficiencies. Because computer
devices have the potential to be more reliable than humans, an
opportunity exists to improve physiologic monitor devices to
reduce the problem of clinical alarm fatigue.
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